PUBLICATIONS · 23358971
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Apr 10
- First author
- Goss PE
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2013 Sep 20;31(27):3439. doi: 10.1200/JCO.2013.49.2884.
- note
- Source null
- related pmid
- 23918949
- relationship
- Comment in
- citation
- J Clin Oncol. 2013 Sep 20;31(27):3439-40. doi: 10.1200/JCO.2013.51.4893.
- note
- Source null
- related pmid
- 23943834
- relationship
- Comment in
Authors and identifiers
- name
- Goss PE
- type
- Author
- name
- Ingle JN
- type
- Author
- name
- Pritchard KI
- type
- Author
- name
- Ellis MJ
- type
- Author
- name
- Sledge GW
- type
- Author
- name
- Budd GT
- type
- Author
- name
- Rabaglio M
- type
- Author
- name
- Ansari RH
- type
- Author
- name
- Johnson DB
- type
- Author
- name
- Tozer R
- type
- Author
- name
- D'Souza DP
- type
- Author
- name
- Chalchal H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Goss PE
- type
- Author
- name
- Ingle JN
- type
- Author
- name
- Pritchard KI
- type
- Author
- name
- Ellis MJ
- type
- Author
- name
- Sledge GW
- type
- Author
- name
- Budd GT
- type
- Author
- name
- Rabaglio M
- type
- Author
- name
- Ansari RH
- type
- Author
- name
- Johnson DB
- type
- Author
- name
- Tozer R
- type
- Author
- name
- D'Souza DP
- type
- Author
- name
- Chalchal H
- type
- Author
- bibliography ids
- nci-bib-68f9eaa42c498e29882313bc
- book metadata
- content sha256
- eb37552aee8fc876008e1f041dc55835b9991fa3256ded680fc7fe50db6d07c7
- document type
- citation
- dois
- 10.1200/JCO.2012.44.7805
- electronic publication date
- display
- 2013 Jan 28
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23358971
- immutable id
- pubmed:23358971@eb37552aee8fc876008e1f041dc55835b9991fa3256ded680fc7fe50db6d07c7
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 11
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1398-404
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2013 Sep 20;31(27):3439. doi: 10.1200/JCO.2013.49.2884.
- note
- Source null
- related pmid
- 23918949
- relationship
- Comment in
- citation
- J Clin Oncol. 2013 Sep 20;31(27):3439-40. doi: 10.1200/JCO.2013.51.4893.
- note
- Source null
- related pmid
- 23943834
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 23358971
- provenance
- batch id
- 99e85dbb34a1a3011c9a
- provider
- NCBI PubMed ESummary
- record sha256
- dc66aaf11816165d4f850891ed026014b477a889a53ed9a20f4451cd7508e6a2
- response sha256
- 1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
- retrieved at
- 2026-09-09T23:46:52.860383+00:00
- publication date
- display
- 2013 Apr 10
- precision
- day
- year
- 2013
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Historical Article
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
Preserved source evidence · Not medical advice
Triangle